Patients with esophageal cancer frequently present with advanced-stage disease. Many surgeons have adopted a policy of recommending esophagectomy to all patients who are fit enough to withstand major surgery, even if it provides no survival benefit. Only those patients who are too ill are referred for endoscopic laser therapy (ELT) or merely gastrostomy. In this study we investigated the short-and long-term results of esophagectomy and ELT in patients with Stages III and IV squamous cell carcinoma of the thoracic esophagus between January 1989 and April 1993. Thirty-three patients (12 at Stage III and 21 at Stage IV) underwent esophagectomy, while 22 patients (4 at Stage III and 18 at Stage IV) had ELT during the same period. Concurrent diseases were more prevalent in the ELT group. In the esophagectomy group, mortality was 19% and 16.7% in patients with Stage III and IV disease, respectively. Major complications were respiratory problems and leakage. Patients who developed major complications stayed an average of almost 100 days in hospital and succumbed shortly after discharge. Patients given ELT had a high mortality due to their severe pre-treatment status. However, those who survived the initial treatment stayed only a few days in hospital with a median survival of 159.5 days. The survival of patients in the two groups did not differ. ELT had the benefit of providing a shorter and cheaper hospital stay even in very advanced cases. It remains to be determined whether ELT patients would have had a final outcome comparable to that of patients offered resection if they had been treated at an earlier stage. (Jpn J Clin Oncol 26: 211-214, 1996) 
Introduction
Esophageal cancer is still one of the most common fatal malignant diseases in both Thailand 1 ' and Western countries. 2 ' For about 100 years, the standard treatment for this disease has been esophageal resection. However, this major form of surgery is still associated with significant mortality and morbidity. 3 ' With the advent of better technology in recent years, surgeons now have more choice for the treatment of this disease, at least in terms of palliation.
Most patients with esophageal cancer present with very advanced disease, which makes curative resection rare. Despite this, many surgeons still offer esophageal resection as the palliative treatment of choice. In our institute, most patients apparently strong enough to tolerate major surgery have been This review of our experiences in recent years addresses the question of whether esophageal resection in patients with advanced cancer has any outcome advantage over a more conservative form of palliation endoscopic laser therapy. It was hoped that our results would clarify whether there was any economic benefit resulting from a shorter hospital stay with a lower incidence of complications. We also examined the survival of these patients, which was not expected to be prolonged by the treatment.
Patients and Methods
During the period between January 1989 and April 1993, 155 patients with thoracic esophageal squamous cell carcinoma were admitted to the Department of Surgery, Ramathibodi Hospital, Bangkok. Of these, 26 were at Stage II, 47 were at Table I shows the treatment modalities used for these patients. The records of patients who underwent palliative esophageal resection and endoscopic laser therapy (ELT) were retrieved. The details of staging, types of treatment, complications, hospital stay and causes of death were reviewed. The current status of each patient was then traced by questionnaire and telephone interview. Each patient was followed until December 1993, so that the shortest follow-up period was 8 months if the patient survived.
All patients with upper and middle thoracic esophageal cancer underwent dissection of the thoracic cavity via a right thoracotomy, and the stomach was brought up and anastomosed with the cervical esophagus. Four patients whose cancer was located in the lower esophagus, resection without thoracotomy was performed.
ELT was performed through an adult-size double working-channel gastroscope after proper dilatation of the narrow segment up to 16 mm using SavaryGillard dilators. The retrograde technique was used, which meant that the gastroscope was first advanced through the tumorous segment and the laser was fired as the endoscope was withdrawn past the tumor. The laser irradiation was passed through a 600-jtm quartz fiber using 90-100-W pulses of 0.4 s. The total energy per ELT session ranged from 4000 to 9000 J. Most patients needed 1-3 sessions for their first admission. Repeated ELT was performed as necessitated by the patient's symptoms of dysphagia, usually about once every 2 months, until death or loss to follow-up. Staging was based on the American Joint Committee on Cancer (AJCC) 1993.
4) The statistical analysis was based on the chi-squared test.
5 ' Survival curves were constructed by the life-table method as recommended in the AJCC Manual for staging of cancer.
'

Results
Average ages of patients at each stage who underwent esophageal resection and ELT did not differ significantly (resection, 64.9; ELT, 65.1). However, there was considerable difference in the incidence of concurrent diseases, as shown in Table  II . This reflected the fact that patients who were offered resection were considered to have a more favorable condition, leaving those who were very ill for ELT treatment. The patients who underwent only gastrostomy or who had no treatment were in even worse condition. Despite this, the distribution of different degrees of differentiation was quite similar between the resection group and the ELT group. Table III shows the complications of patients in both groups. The most common complications in the resection group were respiratory problems and anastomotic leakage, whereas the ELT patients were more prone to tracheo-esophageal fistula (TEF) and pneumonia. This was obviously a continuation of their preoperative status, since TEF was already present in many of them (Table II) .
Causes of hospital death are shown in Table IV . In most cases, death was due to major complications that occurred before and after surgery, except for a few patients who were extremely ill and cachectic on admission. Hospital mortality was 18.2% after resection and 45.4% after ELT, ENDOSCOPIC LASER THERAPY reflecting the different initial status of the two groups. Considering the hospital stay after esophageal resection in this group of patients, those who did not have major complications stayed an average of 22.5 days (range 7-33 days) after surgery. If we excluded those who died within 30 days after surgery, patients who developed major complications stayed an average of 97.3 days after resection (range 54-173 days).
For patients who received ELT, the hospital stay was more constant, ranging between 5 and 15 days. All patients who developed TEF, both before and after ELT, died within a relatively short time after admission. One patient was discharged 10 days after ELT and received radiation treatment, only to return with TEF on the 15th day after irradiation.
Among patients with Stage III cancer, only 8 received additional radiation treatment with or without chemotherapy after resection. Only 7 patients with Stage IV disease received additional treatment modalities after resection. Of the 12 patients who survived their initial hospital stay after ELT, 4 received radiation with or without chemotherapy; the remaining patients failed to attend for follow-up.
Those patients who received ELT and survived their initial hospitalization lived for 74-714 days (mean survival 214 days; median survival 159.5 days). The survival of those patients who underwent esophageal resection was not much better. Although 12 of the total of 33 patients with resection survived the first year, only 3 of them survived the second year, and all of them died before the fourth year. Swallowing ability was assessed and found to be quite satisfactory in the" majority of the survivors, similar to our previous report. 6 ' All patients who were given ELT had died by the time of writing. The final fates of these patients are shown in Table V. All but 3 eventually died as a result of their cancer.
Discussion
This report was not intended to make any comparison between the modalities of treatment for a similar group of patients. The results clearly demonstrated the attitude of our surgeons in selecting the treatment modality for their patients with very advanced disease. Several points need to be raised in the light of the results.
Palliative resection of the esophagus for Stage III and IV squamous cell carcinoma resulted d in a hospital mortality of 18.2%, which was within the acceptable range and comparable to other series. However, the complication rate was high and significant, especially respiratory problems and leakage, which usually resulted in death or a prolonged hospital stay. If major complications occurred, the patients were likely to stay an average of about 100 days in hospital, receiving expensive antibiotics and parenteral nutrition, simply to enable their discharge, which was invariably followed by short survival.
ELT, on the other hand, was associated with a high hospital mortality in this series. This was easily understandable, since only patients with a very poor physical status were offered this modality. However, if the patients survived the initial treatment, their hospital stay was short, and the resulting investment was low. No expensive antibiotics were necessary in most cases, and no parenteral nutritional support was given, since complications necessitating its use were rare. Aside from the complications which were likely to have resulted from their previous status, the morbidity from the procedure itself was much lower. Swallowing ability after successful treatment was satisfactory. Although successful surgical resection might have brought more swallowing benefit, improved survival could never be guaranteed, as shown in the present results.
It should be stressed that ELT was used exclusively for palliation and did nothing for the status of the tumor. ELT was indicated only when the patients suffered from severe dysphagia. Thus if prolongation of life is expected in any patient, ELT should never be employed alone. It is contraindicated in patients with known or suspected bronchial invasion, since this would result in the development of TEF. Such patients would be more likely to benefit from a colon bypass or endoscopic intubation.
Radiotherapy for esophageal squamous cell carcinoma is an alternative for advanced disease. ELT could well be combined with irradiation in patients who had severe difficulty in swallowing, so that their nutritional status could be improved while they were receiving definitive therapy. However, this combination is not advisable in patients with bronchial invasion or with TEF. For patients who are proved to be free from bronchial invasion, a combination of ELT, irradiation and chemotherapy might also be considered.
With regard to the high mortality after ELT described in this report, an important question can be raised: if patients considered strong enough to withstand major surgery were to be offered ELT as an alternative, would the final outcome be comparable to that of palliative resection?
If the patients not in severe condition before treatment, for example, those with tracheoesophageal fistula or aspiration pneumonia, were excluded, deaths from respiratory failure and tracheo-esophageal fistulae would be zero. This, in combination with the lower operative complication rate, would result in a better outcome, albeit without survival benefit, although a prospective randomized study will be necessary to prove this. However, whether or not surgeons would agree to undertake such a study would involve overcoming their entrenched attitude that surgical resection of any malignant tumor will always be the best palliation.
